Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05758142 · ClinicalTrials.gov registry record · NA
Potassium Intake-response Trial to Control Hypertension
A NA study, sponsored by Tulane University.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05758142: Clinical Trial NA study, sponsored by Tulane University.
NCT05758142 is a NA study that was terminated before completion, run by Tulane University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05758142, a NA study, was terminated before completion, sponsored by Tulane University.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The Potassium Intake-response Trial to Control Hypertension (PITCH) will test the intake-response relationship between potassium supplementation and blood pressure, which may inform clinical guidelines on the optimal level of potassium supplementation for blood pressure lowering among adults with elevated blood pressure or hypertension and dietary guidelines for population intake.
Primary Outcome
Ambulatory blood pressure monitoring will be used to determine 24-hour systolic BP
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Potassium Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2024-05-03 |
| Phase | NA |
Why NCT05758142 stopped before completion
NCT05758142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05758142 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05758142 about?
NCT05758142 is a clinical study titled "Potassium Intake-response Trial to Control Hypertension". The Potassium Intake-response Trial to Control Hypertension (PITCH) will test the intake-response relationship between potassium supplementation and blood pressure, which may inform clinical guidelines on the optimal level of potassium supplementation for blood pressure lowering among adults with el...
What is the current status of trial NCT05758142?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2023-03-29. Estimated completion is 2024-05-03.
What interventions are being tested in trial NCT05758142?
The interventions under investigation include: Placebo (OTHER), Potassium Chloride (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05758142?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05758142's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI